Travaux scientifiques

Prof. Dr. Cafer Adıgüzel

142 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Increased Antithrombotic And Bleeding Effects Of Contaminated Heparins; Hematological Implications”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-385, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)

    Source : page de profil sur medicana.com.tr

  2. B17. Walenga, J., C. Adiguzel ,J. Cunanan, D. Hoppensteadt, O. Iqbal ve M. Bakhos. “

    Source : page de profil sur medicana.com.tr

  3. Fibrin Clot Formation Differs In The Presence Of Branded And Generic Enoxaparins”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-387, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)

    Source : page de profil sur medicana.com.tr

  4. B18. Hoppensteadt, D., O. Iqbal, C. Adiguzel, J. Cunanan ve J. Fareed. “

    Source : page de profil sur medicana.com.tr

  5. Upregulation Of Procalcitonin In Cancer Patients With Venous Thrombosis”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-482, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)

    Source : page de profil sur medicana.com.tr

  6. B19. Iqbal, O., C. Adiguzel, J. Fareed, D. Hoppensteadt, E. Litinas, H. Zhu, ve A Halaris. “Selective Serotonin Reuptake Inhibitors Influence Agonist-Induced Platelet Aggregation. Preliminary Results from Comorbidity of Depression and Cardiovascular Disease Study”. Blood, 112, 4556, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source : page de profil sur medicana.com.tr

  7. B20. Bansal, V., J. Cunanan, C. Adiguzel, E. Litinas, K. Nelson, ve J. Fareed. A Higher “Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin”. Blood, 112, 3022, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008).

    Source : page de profil sur medicana.com.tr

  8. B21. Zhu, H., D. Hoppensteadt, R. L. Bick, C. Adiguzel, R. Wahi ve Jawed Fareed. “Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins”. Blood 112, 5463, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source : page de profil sur medicana.com.tr

  9. B22. Fareed, J., D. Hoppensteadt, W. Jeske, C. Adiguzel, O. Iqbal ve J.M. Walenga. “Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions”. Blood, 112, 4048, 2009, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source : page de profil sur medicana.com.tr

  10. B23. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt ve J. Fareed. “Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities”. Blood, 112, 4078, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source : page de profil sur medicana.com.tr

  11. B24. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt ve J. Fareed. “Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses”. Blood, 112, 4079, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008).

    Source : page de profil sur medicana.com.tr

  12. B25. Fareed, J., O. Iqbal, D. Hoppensteadt, C. Adiguzel, M. Iacobelli ve J.M. Walenga. “Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins”. Blood, 112: 4086, 2008;. (50. ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source : page de profil sur medicana.com.tr

  13. B26. Adiguzel, C., D. Hoppensteadt, J. Cunanan, R. Bick, J. Walenga ve J. Fareed “Prevalence of heparin induced thrombocytopenia antibodies in cancer patients treated with a low molecular weight heparin”. J Clin Oncol (May 20 suppl) 26, abstr 20601, 2008, (2008 ASCO Annual Meeting, Chicago, USA).

    Source : page de profil sur medicana.com.tr

  14. B27. Fareed, J., O. Iqbal, D. Fareed, D. Hoppensteadt, C. Adiguzel ve J. Cunanan “Upregulation of procalcitonin in cancer patients with venous thrombosis is independent of sepsis”. J Clin Oncol (May 20 suppl), 26, abstr 20583, 2008, (2008 ASCO Annual Meeting, Chicago, USA).

    Source : page de profil sur medicana.com.tr

  15. B28. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes, J. Fareed, J. Walenga,. “Distinct batches of branded parnaparins have differents HIT sera mediated platelet aggregation”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 93, 2008.

    Source : page de profil sur medicana.com.tr

  16. B29. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes ve J. Fareed. “Generic versions of LMWH can be differenciated in HIT sera mediated platelet aggregation”. XXIII World Congress of the International Union of Angiology, Athens, (Oral Presentation), 93, 2008.

    Source : page de profil sur medicana.com.tr

  17. B30. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes, K. Nelson ve J. Fareed. “The inhibition of microparticles generation, platelet aggregation and activation by enoxaparin”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

    Source : page de profil sur medicana.com.tr

  18. B31. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan, E.Ramacotti, M. Gomes, K. Nelson ve J. Fareed. “Danaparoid mediated inhibition of microparticles generation, platelet aggregation and P-selectin expression”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

    Source : page de profil sur medicana.com.tr

  19. B32. Ramacotti, E., M. Gomes, C. Adiguzel, A.Comerota, D. Hoppensteadt , A. Nicolaides ve J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic Biochimico- Cutenox-CT), 40 mg o.d 6-14 days in acutely medically ill patients”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 82, 2008.

    Source : page de profil sur medicana.com.tr

  20. B33. Gomes, M., E.Ramacotti, C. Adiguzel, A. Comerota, D. Hoppensteadt , A. Nicolaides ve J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic Biochimico- Cutenox-CT), 40 mg o.d 10 days in healthy volunteers”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

    Source : page de profil sur medicana.com.tr

  21. B34. Walenga, J, V. Bansal, D. Hoppensteadt, C. Adiguzel, H. Messmore, R. Bick ve Jawed Fareed. “Decrease prevalance of antiheparin platelet factor 4 antibodies in end steage renel disease”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 68, 2008.

    Source : page de profil sur medicana.com.tr

  22. B35. Clark M., D. Hoppensteadt , J. Cunanan, C. Adiguzel, R. Leinhardt ve J. Fareed. “Molecular profiling of a heparinase resistant glycosaminoglycan in contaminated heparins. Comparative studies with noncontaminated heparin and O-sulfonated chodroitin sulfate”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 65,2008.

    Source : page de profil sur medicana.com.tr

  23. B36. Zhu, H., D. Hoppensteadt , J. Cunanan, C. Adiguzel, L. Bick ve J. Fareed. “Reduced immunogenic potential of membrane filtered bovine thrombine preparations for hemostatic application”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 27, 2008.

    Source : page de profil sur medicana.com.tr

  24. B37. Clark, M., D. Hoppensteadt , J. Cunanan, C. Adiguzel, R. Leinhardt ve J. Fareed. “Comparative anticoagulant and antiprotease actions of O-sulfated chondroitin sulfate (OSCS), unfractionated heparin (UFH), and their mixtures”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 25, 2008.

    Source : page de profil sur medicana.com.tr

  25. B38. Walenga, J., W. Jeske, D. Hoppensteadt, O. Iqbal, C. Adiguzel, H. Messmore ve J. Fareed. “Differential heparin-induced thrombocytopenic potential of low molecular weight heparins”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 25 , 2008.

    Source : page de profil sur medicana.com.tr

  26. B39. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “Suledoxide mediated inhibition of tissue factor activation of platelet a potential mechanism for the observed therapeutic effects in diabetic nephropathy”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#4281, 2008.

    Source : page de profil sur medicana.com.tr

  27. B40. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “Comparative anticoagulant effects of suledoxide and enoxaparin in citrated whole blood”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#2388, 2008.

    Source : page de profil sur medicana.com.tr

  28. B41. Samiccannu, M.R., C. Adiguzel , O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “The inhibition of microparticle generation by anticoagulant drugs”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#7073, 2008.

    Source : page de profil sur medicana.com.tr

  29. B42. Hoppensteadt, D., V. Bansal, J. Cunanan, K. Patel, C. Adiguzel, R. Wahi ve J. Fareed. “Prevalence of non-specific cross-reactive epitopes to bovine factor VA light chain fragments in end stage renal disease, acute coronary syndrome and burn patient plasma”. Haemostaseologie (52. GTH Annual Meeting Abstracts), A 93, 2008.

    Source : page de profil sur medicana.com.tr

  30. B43. Adiguzel, C., O. Iqbal, M. Sammikannu, J. Cunanan, W. Jeske, D. Hoppensteadt, ve J. Fareed. “Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation Assays”. Blood, 110, 4007, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source : page de profil sur medicana.com.tr

  31. B44. Adiguzel, C., O. Iqbal, D. Fareed, D. Hoppensteadt, W. Jeske, M.Sammikannu ve J. Fareed. “Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications”. Blood; 110, 3898, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source : page de profil sur medicana.com.tr

  32. B45. Iqbal, O., C. Adiguzel, D. Hoppensteadt, J. Cunannan, ve J. Fareed. “Factor Xa Inhibitors Can Be Differentiated İn Xa, Iıa And Microparticle Generation And Other Whole Blood Based Assays”. Blood, 110, 931,2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source : page de profil sur medicana.com.tr

  33. B46. Demir, M., A. Ciftci, D. Hoppensteadt, G. Altiay, M. Tobu, O. Iqbal, D. Fareed, C. Adiguzel, M. Kujawski ve J. Fareed. “ProteinChip Array Profiling and Markers of Inflammation and Thrombin Generation in Plasma Samples from Lung Cancer Patients and Their Modulation by Chemotherapy with or without Warfarin Anticoagulation”. Blood, 110, 3978, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source : page de profil sur medicana.com.tr

  34. B47. Kujawski, M.R, M. Prechel, H. Zhu, J. Walenga, D. Hoppensteadt, J. Cunanan, C. Adiguzel ve J. Fareed. “A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples”. Blood, 110, 3205, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source : page de profil sur medicana.com.tr

  35. B48. N. Fabbrini, D. Hoppensteadt, H. Messmore, R. Bick, C. Adiguzel ve J. Fareed. “Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome: Potential Implication in Inflammatory Responses and Thrombosis”. Blood, 110, 1740, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source : page de profil sur medicana.com.tr

  36. B49. Adıgüzel C, Kaygusuz I, Birtaş Ateşoglu E, Noyan F, Çetiner M, Demiralp E, Fıratli-Tuğlular T, Bayık M. Chronic Myelogenous Leukemia occurring in mother and son. 1st International Lymphoma-Leukemia-Myeloma Congress, Abstract No:139, page 116, Fethiye/Muğla, 24-27 May 2007

    Source : page de profil sur medicana.com.tr

  37. B50. Adıgüzel, C., S. Uyar-Bozkurt, T. Tecimer, E. Birtaş, I. Kaygusuz, F. Noyan, A. Uzay ve M. Bayık. “HHV-8 Negative Primary Effusion Lymphoma in a HIV Negative Patient” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source : page de profil sur medicana.com.tr

  38. B51. Uzay, A., C. Adıgüzel, M. Demir, M. Bayık. “The in vitro Effect of Different Molecular Weight Hydroxyethyl Starch Solutions and Saline on Platelet Aggregation” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source : page de profil sur medicana.com.tr

  39. B52. Noyan, F., E. Birtaş, C. Adıgüzel, I. Kaygusuz, M. Çetiner, , T. Fıratlı-Tuğlular ve M. Bayık, , “A VAD Therapy Resistant Multiple Myeloma Transformed From CLL” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source : page de profil sur medicana.com.tr

  40. B53. Birtaş, E., Z. Odabaşı, T. Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, V. Korten ve M. Bayık. “Epidemiology of Bacterial Infections in Febrile Neutropenic Patients Having Hematological Malignancies in Marmara University Hospital, İstanbul, Turkiye” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source : page de profil sur medicana.com.tr

  41. B54. Eksioglu-Demiralp,E., P. Bizargity, C. Adiguzel, G. Ozilhan ve M. Bayik. “Imatinib Does Not Inhibit Neutrophil Oxidative Burst Function in Patients with Chronic Myelogenous Leukemia (CML)”. The American Society of Hematology 46th Annual Meeting and Exposition, December 9-12, USA. , Blood (ASH Annual Meeting Abstracts, 104: Abstract 4673 ) 2004

    Source : page de profil sur medicana.com.tr

  42. B55. Çetiner, M., S. Kalaça, S. Ratip, Ç. Yazgan, C. Adıgüzel, S. Kalayoğlu-Beşışık, D. Argon, I. Kaygusuz, G. Aktuğlu ve M. Bayık, “Quality of Life Assessment of Haematopoietic Stem cell Transplantationpatients in İstanbul: a Pilot Study,” 30th Annual Meeting of the European Group for Blood and Marrow Transplantation, Barcelona, Bone Marrow Transplantation, Vol. XXXIII, 2004

    Source : page de profil sur medicana.com.tr

  43. B56. Adıgüzel, C., M. Sönmezoğlu, D. Argon, T. Akdeniz, E.Z. Demiralp ve M. Bayık. “Effects of irradiation and filtration on viability of platelets”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, pg24, 5-9 Temmuz 2003.

    Source : page de profil sur medicana.com.tr

  44. B57. Yüksel, M., D. Argon, C. Adıgüzel, M. Sönmezoğlu, M. Bayık ve S. Yalçın. “Effects of gamma irradiation and storage on apheresis platelets: The role of reactive oxygen species”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, 5-9 Temmuz 2003, pg 5

    Source : page de profil sur medicana.com.tr

  45. B58. Sönmezoğlu, M., D. Argon, C. Adıgüzel ve M. Bayık. “Evaluation of storage conditions of blood bank by measuring of free hemoglobin in red cell concentrates and whole blood”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, pg55, 5-9 Temmuz 2003.

    Source : page de profil sur medicana.com.tr

  46. B59. Argon, D., M. Sönmezoğlu, C. Adıgüzel ve M. Bayık. “Effects of prestorage leukocyte depletion on the platelet storage lesion”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, 5-9 Temmuz 2003, pg55

    Source : page de profil sur medicana.com.tr

  47. B60. Kartı, S.S., S. Ratip, M. Yılmaz, S. Ukınç, A. Örem, C. Adıgüzel, F. Dane, N. Kandemir, E. Ovalı ve M. Bayık. “Therapeutic Trial of Cobalamin in Patients with Normal Serum Cobalamin Levels and Predicted Cobalamin Deficiency”. 7 th Meeting of the European Hematology Association, Florence, İtaly, The Hematology Journal suppl., Vol. 3. 2002.

    Source : page de profil sur medicana.com.tr

  48. D1. Birtaş-Ateşoğlu, E., T.Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, M. Bayık. “A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate”, Tr J Haematol, 24, 28-31 (2007)

    Source : page de profil sur medicana.com.tr

  49. D2.Kaygusuz, I., Z. Odabaşı, C. Adıgüzel, F. Noyan, E. Birtaş, V. Korten, T. Fıratlı-Tuğlular, M. Çetiner, M Bayık. “Complete heart block in a neutropenic patient with invasive aspergillosis”, Tr J Haematol, 23, 205-208 (2006)

    Source : page de profil sur medicana.com.tr

  50. D3.Çetiner, M., T. Fıratlı-Tuğlular, Y. Özen-Al Ahdab, H. Al Ahdab, M. Köse, F. Noyan, C. Adıgüzel, E. Ovalı, M. Bayık. “Amifostine treatment in patients with myelodysplastic syndrome” Turk J Haematol, 22, 117-123 (2005)

    Source : page de profil sur medicana.com.tr